申请人:AMERICAN CYANAMID COMPANY
公开号:EP0117462A2
公开(公告)日:1984-09-05
This disclosure describes novel N-[ω-(1H-imidazol-1-yl)alkyl]arylamides which possess the property of inhibiting the enzyme thromboxane synthetase and are also useful in the treatment of hypertension and myocardial ischemia.
本公开介绍了新型 N-[ω-(1H-咪唑-1-基)烷基]芳基酰胺,它们具有抑制血栓素合成酶的特性,还可用于治疗高血压和心肌缺血。